e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary vascular diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Progression of endothelial dysfunction in relationship with development of pathomorphological changes in monocrotalin-induced model pulmonary hypertension in rats
A. Fedorowicz, T. Skorka, A. Jakubowski, M. Walczak, J. Szymura-Oleksiak, S. Chlopicki (Krakow, Poland)
Source:
Annual Congress 2010 - Pulmonary vascular diseases
Session:
Pulmonary vascular diseases
Session type:
Thematic Poster Session
Number:
4491
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Fedorowicz, T. Skorka, A. Jakubowski, M. Walczak, J. Szymura-Oleksiak, S. Chlopicki (Krakow, Poland). Progression of endothelial dysfunction in relationship with development of pathomorphological changes in monocrotalin-induced model pulmonary hypertension in rats. Eur Respir J 2010; 36: Suppl. 54, 4491
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001
Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model.
Source: International Congress 2017 – Experimental PH
Year: 2017
Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2015; 46: 431-443
Year: 2015
Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Year: 2021
Inflammatory changes in a murine model of monocrotaline-induced pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 365s
Year: 2005
Loss of Bmp9 does not lead to spontaneous pulmonary hypertension, but attenuates vascular remodeling in experimental models
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007
Primary pulmonary hypertension and endothelial dysfunction
Source: Eur Respir J 2003; 22: Suppl. 45, 583s
Year: 2003
Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007
Pulmonary hypertension: the science behind the disease spectrum
Source: Eur Respir Rev 2012; 21: 19-26
Year: 2012
Altered control of cerebral circulation in chronic obstructive pulmonary disease: an early sign of cardiovascular autonomic dysfunction
Source: Annual Congress 2008 - COPD
Year: 2008
In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Novel hypoxia system to assess endothelial dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction
Source: Eur Respir J 2014; 44: 160-168
Year: 2014
Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017
Year: 2018
Two rat models of hemolysis-induced pulmonary hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Association of renal dysfunction with hemodynamics and survival in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept